MICHELLE LADEWIG: Open Payments
NPI 1821447434 · GAINESVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$858 in 41 payments from 17 companies in 2025. Trend: 2023 $1,030 · 2024 $810 · 2025 $858
Food & beverage: $858
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $261 |
| PFIZER INC. | 4 | $73 |
| Lilly USA, LLC | 4 | $69 |
| Amgen Inc. | 3 | $63 |
| Edwards Lifesciences Corporation | 2 | $58 |
| Eisai Inc. | 2 | $47 |
| ABBVIE INC. | 3 | $46 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $35 |
| Novo Nordisk Inc | 2 | $32 |
| Exact Sciences Corporation | 2 | $32 |
Products named: TEZSPIRE, OTEZLA, SAPIEN 3 Ultra RESILIA, PREVNAR 20, MOUNJARO, Leqembi, AIRSUPRA, JARDIANCE.
Industry payments across GA — which companies pay providers there.
